HempToday's Kehrt Reyher discusses industrial hemp policy, CBD regulation, and market development. Insights cover legislative ...

Explore how U.S. Congressional actions are impacting industrial hemp businesses and the proposed marijuana rescheduling, ...

Explore the US Justice Department's reclassification of medical cannabis to Schedule III, impacting tax breaks for businesses ...

A Travis County district judge has extended a temporary injunction, allowing Texas shops to continue selling smokable hemp ...

The DEA clarifies hexahydrocannabinol (HHC) is a federally illegal Schedule I substance, assigning it a new drug code. This ...

Explore how federal cannabis rescheduling could activate existing South Carolina laws, potentially granting patients medical ...

A new poll reveals 75% of Texas voters support medical cannabis reforms, despite low awareness of the state's Compassionate ...

The U.S. House passed the Farm Bill, leaving federal rules for hemp-derived cannabinoids unchanged. Learn how this impacts ...

The US Department of Justice's move to reclassify medical cannabis to Schedule III could unlock critical research ...

Texas industrial hemp businesses are challenging state regulations banning smokable products and increasing licensing fees.

CAURD Inc. outlined a three-point plan to stabilize New York's equity cannabis market. This advocacy aims to refine cannabis ...

Explore how potential US federal medical cannabis reclassification could impact market dynamics, regulatory frameworks, and ...